Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"Dual acting"”.
-
RATIONAL DESIGN OF ALLOSTERIC MODULATORS OF HEMOGLOBIN AS DUAL ACTING ANTISICKLING AGENTS
… TD-7 after reaching maximum effect at 1 h gradually decreased in potency and at 24 h has lost 45% of its activity, consistent with the low bioavailability of this compound. These findings suggested that our modifications appeared to successfully limit drug metabolism in red blood cells. Most …
-
Design and synthesis of dual acting carbamate inhibitors of acetylcholinesterase and monoamine oxidase
… are urgently required. It is postulated that a dual MAO-B and AChE inhibitor would improve motor symptoms of PD while improving cognitive deficits at the same time. Such an agent would not only be useful in the treatment of PD, but also in PDD and AD as the MAO inhibition component has the …
-
Synthesis and Evaluation of Dual-Acting Ligands for Mu Opioid And Neuropeptide FF Receptors
… the design and synthesis of small molecule, dual-acting ligands that act as MOP agonists and NPFF antagonists are a viable approach to opioid analgesics. These ligands would provide the necessary opportunity to provide analgesia, while also blocking a physiological tolerance development …
-
THE EFFECT OF NOVEL MICROTUBULE MODULATORS ON EXPERIMENTAL LEWY BODY DISEASE
… objective of the present study was to evaluate dual-acting microtubule- stabilizing/destabilizing agents in cellular and animal models of early-stage Lewy body disease. In Aim 1 we tested the dual-acting tricylic pyrimido[4,5-b]indole analogs AG161-47 and AG161-41 in an in vitro preformed fibril …
-
DISCOVERY OF INDOLYL PIPERAZINYLPYRIMIDINES WITH DUAL-TARGET PROFILES ADENOSINE A2¿ AND DOPAMINE D2 RECEPTORS FOR PD TREATMENT
… IPP-CONTAINING COMPOUNDS LED TO THE DISCOVERY OF DUAL-ACTING COMPOUNDS 69 AND 70.
-
Development of Hybrid GPCR Ligands: Photochromic and Butyrylcholinesterase Inhibiting Human Cannabinoid Receptor 2 Agonists
… the previous chapters, a first investigation of dual-acting compounds that address both hCB2R and BChE was illustrated (figure 6.1). A set of over 30 compounds was obtained by applying SARs from BChE inhibitors to a hCB2R selective agonist developed by AstraZeneca. In a first in vitro evaluation …
-
The Genetic Hierarchy of the Heterochronic Pathway in C. elegans
… Finally, my work has helped to uncover the dual-acting nature of two proteins in this pathway, LIN-28 and HBL-1. The two-step mechanisms of the proteins in this pathway are an emerging theme of developmental timing, where they act once to promote a specific cell lineage, and again to block …
-
Rational approaches towards the design of (E)-8-(3-Chlorostyryl)-caffeine derivatives as novel reversible inhibitors of monoamine oxidase B
… agents in PD, the possibility of designing dual acting anti-parkinsonian drugs that can act both as A2A antagonists and inhibitors of MAO-B may be of value. In PD such dual acting drugs could potentially enhance motility through antagonism of A2A receptors and protect against further …
-
Target Based Design And Synthesis of Heterocycles in the Potential Treatment of Cancer and Opportunistic Infection
… /> Multitargeted single agents with dual mechanism of actions, containing both cytostatic and cyotoxic components are particularly relevant to cancer chemotherapy as they have the potential to overcome multidrug resistance and dose limiting toxicities. Antiangiogenic agents target …
-
The synthesis and evaluation of caffeine analogues as inhibitors of monoamine oxidase B and antagonists of the adenosine A₂A receptor
… also been employed as anti-parkinsonian agents, dual-targetdirected drugs that block both MAO-B and A2A receptors may have enhanced value in the management of PD. In an attempt to identify additional dual-acting compounds, we have, in the present study, synthesised 3 additional classes of C-8 …
-
Μελέτη ενζύμων του μεταβολισμού των υδατανθράκων που σχετίζονται με την παθοφυσιολογία του διαβήτη με έμφαση στην DPP-4 και PTP1b και της δυνατότητας εύρεσης ειδικών αναστολέων με πιθανή εφαρμογή στη θεραπεία και τη διαγνωστική
… on allosteric inhibitors, the discovery of dual-acting inhibitors, as well as the investigation of DPP4 isoform variations in serum from patients with T2DM, other DPP4-related pathological conditions(cancer, Alzheimer’s disease), and healthy individuals. For this purpose, sixteen synthetic …
-
Development of novel therapeutic approaches: (I) Targeting allergic responses to peanuts and (II) Inhibition of DPP-IV enzyme involved in diabetes
… for diabetes; however, we aimed to develop dual acting compounds that would not only control type 2 diabetes but also commonly associated diagnosis of hypertension as well. Thus, we have successfully synthesized and tested compounds in vitro as effective dipeptidyl peptidase-IV (DPP-IV) …
-
Active, polymer-based composite material implementing simple shear
… shear actuator was modeled as were single-acting and dual-acting shear actuator arrays so that solitary and multi-cell behaviors were estimated. Actuator work performance and power from nonlinear finite element analysis found conventional work density is 0.2289 MJ/m3 and 0.2482 MJ/m3, for …
-
The design, synthesis and evaluation of aminocaffeine derivatives as inhibitors of monoamine oxidase B
… also produces an antiparkinsonian effect, dual acting compounds such as CSC, which block both the A2A receptors and MAO-B, may have an enhanced therapeutic potential in PD therapy. Current PD therapy available only treats the symptoms of PD and do not halt or slow the progression of the …
-
Improving Reciprocating Compressor Valve Condition Monitoring via an Accelerated Lifetime Tester and Deep Learning
… into all the valves of a Dresser-Rand ESH-1 dual-acting reciprocating compressor. The method converts raw vibration data into the time-frequency domain and determines if the Continuous Wavelet Transformation or the Smoothed Pseudo Wigner-Ville Spectrum can achieve a higher classification …
-
Neural Correlates of Treatment in Depression and Potential Predictors of Diagnosis and Clinical Response
… in depression. In Chapter 3, the effects of a dual acting serotonin norepinephrine reuptake inhibitor, duloxetine, on affective biases are examined using implicit affective paradigms comprising happy and sad facial expressions. Chapter 4 investigates the neural effects of duloxetine on working …
-
Synthesis, biological activity and physicochemical properties evaluation of antiplasmodial pyrimido[1,2-a]benzimidazoles
… an IC50 of 0.244 μM, confirming this to be a dual-acting antiplasmodium agent. Strategies adopted to improve solubility involved incorporation of hydrogen bonding donors and acceptors, the introduction of polar-ionisable or neutral polar groups, or the disruption of molecular planarity. The …
-
Targeting Tau Degradation by Small Molecule Inhibitors for Treatment of Tauopathies
… shown to propagate from cell to cell potentially acting as a signaling molecule that contributes to disease progression. In addition during disease, tau mislocalizes to dendrites leading to synaptic dysfunction. This mislocalization may also lead to subsequent neurodegeneration. Today, many …
-
Non-invasive drug delivery to the posterior segment of the eye: Development of formulation strategies and evaluation of ocular distribution and pharmacological activity
… CB1 and CB2, could potentially be such a dual acting anti-glaucoma agent. Delivering therapeutic levels of THC into the inner ocular layers is very challenging due to the extremely lipophilic characteristics of THC. A synthetic amino acid dicarboxylic acid prodrug of THC, …
Page 1 of 2